Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3253975 | 1.00 | HSD17B10 (0.47) | HSD17B10MEN1KMT2AKDM4EMAPT | |
| SCHEMBL28316412 | 0.92 | ALDH1A1 (0.47) | HSD17B10MEN1KMT2AKDM4EMAPT | |
| SCHEMBL1065970 | 0.92 | MEN1 (0.47) | HSD17B10MEN1KMT2AKDM4EMAPT | |
| SCHEMBL7335158 | 0.90 | HSP90AA1 (0.49) | HSD17B10MEN1KMT2AKDM4EMAPT | |
| SCHEMBL8748376 | 0.87 | HTR2C (0.51) | MEN1KMT2AKDM4EMAPTL3MBTL1 | |
| SCHEMBL9349844 | 0.83 | ALDH1A1 (0.42) | HSD17B10MEN1KMT2AKDM4EMAPT | |
| SCHEMBL9349842 | 0.83 | ALDH1A1 (0.42) | HSD17B10MEN1KMT2AKDM4EMAPT | |
| SCHEMBL27973468 | 0.82 | TDP1 (0.45) | HSD17B10MEN1KMT2AKDM4EMAPT | |
| SCHEMBL28522110 | 0.81 | TDP1 (0.44) | HSD17B10MEN1KMT2AKDM4EMAPT | |
| SCHEMBL18840407 | 0.81 | TDP1 (0.44) | HSD17B10MEN1KMT2AKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4545515-A1 | BCL-2 INHIBITORS | BeiGene Switzerland GmbH (CH) | 2025-04-30 | — | — | EP | disclosed |